Copy number variations in atypical fibroxanthomas and pleomorphic dermal sarcomas.

作者: Doris Helbig , Alexander Quaas , Cornelia Mauch , Sabine Merkelbach-Bruse , Reinhard Büttner

DOI: 10.18632/ONCOTARGET.22691

关键词: Cancer researchCDKN2AGene mutationMutationAtypical fibroxanthomaIDH1PDGFRACopy-number variationTumor progressionMedicine

摘要: Atypical fibroxanthomas (AFX) and pleomorphic dermal sarcomas (PDS) are frequent cutaneous typically arising on sun-exposed skin in elderly patients. In contrast to AFX, which generally do not recur after complete excision, PDS locally up 50% metastasize 20%. We recently detected characteristic UV-induced TP53 mutations as potential driver mutation almost all investigated well activating PIK3CA RAS gene around one third of our tumors representing targets for personalized treatments patients with unresectable or metastasized PDS. the present study, we identified amplifications deletions a small part (6 27 cases) but AFX suggesting that copy number variations (CNV) might be an initial event tumor development rather important during progression. addition BRAF, KNSTRN, IDH1 PDGFRA amplification, CNV analyses revealed CDKN2A, KIT genes. cases where appropriate FISH assay was established, results could verified by analysis. Amplification and/or losses CDKN2A represent bad prognostic markers, although larger studies needed clarify their association prognosis progression

参考文章(48)
Philipp U Heitz, Angela Baer, Bruno Paredes, Daniela Mihic-Probst, Paul Komminoth, Parvin Saremaslani, Jianming Zhao, Christian Oehlschlegel, CGH analysis shows genetic similarities and differences in atypical fibroxanthoma and undifferentiated high grade pleomorphic sarcoma. Anticancer Research. ,vol. 24, pp. 19- 26 ,(2004) , 10.5167/UZH-111580
Karolina A. Pesz, Andrzej Bieniek, Izabela Makowska, Maria M. Sąsiadek, Basal cell carcinoma of the skin: whole genome screening by comparative genome hybridization revisited Journal of Cutaneous Pathology. ,vol. 40, pp. 25- 29 ,(2013) , 10.1111/CUP.12033
Philip E. LeBoit, Eva-Bettina Bröcker, Boris C. Bastian, Henning Hamm, Dan Pinkel, Chromosomal Gains and Losses in Primary Cutaneous Melanomas Detected by Comparative Genomic Hybridization Cancer Research. ,vol. 58, pp. 2170- 2175 ,(1998)
Zofia Hélias-Rodzewicz, Elisa Funck-Brentano, Laure Baudoux, Chan Kwon Jung, Ute Zimmermann, Cristi Marin, Thierry Clerici, Catherine Le Gall, Frédérique Peschaud, Valérie Taly, Philippe Saiag, Jean-François Emile, None, Variations of BRAF mutant allele percentage in melanomas BMC Cancer. ,vol. 15, pp. 497- 497 ,(2015) , 10.1186/S12885-015-1515-3
Liza C. Villaruz, Mark A. Socinski, Shira Abberbock, Lynne D. Berry, Bruce E. Johnson, David J. Kwiatkowski, A. John Iafrate, Marileila Varella-Garcia, Wilbur A. Franklin, D. Ross Camidge, Lecia V. Sequist, Eric B. Haura, Mark Ladanyi, Brenda F. Kurland, Kelly Kugler, John D. Minna, Paul A. Bunn, Mark G. Kris, Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium Cancer. ,vol. 121, pp. 448- 456 ,(2015) , 10.1002/CNCR.29042
Melissa A. Wilson, Fengmin Zhao, Sanika Khare, Jason Roszik, Scott E. Woodman, Kurt D'Andrea, Bradley Wubbenhorst, David L. Rimm, John M. Kirkwood, Harriet M. Kluger, Lynn M. Schuchter, Sandra J. Lee, Keith T. Flaherty, Katherine L. Nathanson, Copy Number Changes Are Associated with Response to Treatment with Carboplatin, Paclitaxel, and Sorafenib in Melanoma Clinical Cancer Research. ,vol. 22, pp. 374- 382 ,(2016) , 10.1158/1078-0432.CCR-15-1162
Joanna J. Phillips, Derick Aranda, David W. Ellison, Alexander R. Judkins, Sidney E. Croul, Daniel J. Brat, Keith L. Ligon, Craig Horbinski, Sriram Venneti, Gelareh Zadeh, Mariarita Santi, Shengmei Zhou, Christina L. Appin, Stefano Sioletic, Lisa M. Sullivan, Maria Martinez-Lage, Aaron E. Robinson, William H. Yong, Timothy Cloughesy, Albert Lai, Heidi S. Phillips, Roxanne Marshall, Sabine Mueller, Daphne A. Haas-Kogan, Annette M. Molinaro, Arie Perry, PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma Brain Pathology. ,vol. 23, pp. 565- 573 ,(2013) , 10.1111/BPA.12043
Caroline Robert, Boguslawa Karaszewska, Jacob Schachter, Piotr Rutkowski, Andrzej Mackiewicz, Daniil Stroiakovski, Michael Lichinitser, Reinhard Dummer, Florent Grange, Laurent Mortier, Vanna Chiarion-Sileni, Kamil Drucis, Ivana Krajsova, Axel Hauschild, Paul Lorigan, Pascal Wolter, Georgina V Long, Keith Flaherty, Paul Nathan, Antoni Ribas, Anne-Marie Martin, Peng Sun, Wendy Crist, Jeff Legos, Stephen D Rubin, Shonda M Little, Dirk Schadendorf, None, Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib The New England Journal of Medicine. ,vol. 372, pp. 30- 39 ,(2015) , 10.1056/NEJMOA1412690
Boris C. Bastian, Rosaura Esteve-Puig, Targeting Activated KIT Signaling for Melanoma Therapy Journal of Clinical Oncology. ,vol. 31, pp. 3288- 3290 ,(2013) , 10.1200/JCO.2013.50.3227